Bioceres Crop Solutions (BIOX)
NASDAQ:BIOX
Want to see BIOX full AI Analyst Report?
Earnings Data
Report Date
Sep 03, 2026Before Open (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
―Last Year’s EPS
-0.7Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Negative
The call outlined decisive strategic actions (new CFO hire, asset-light shift in seeds, cost controls, liability management) and one segment showing revenue growth (Crop Nutrition). However, these positives were outweighed by material near-term financial deterioration: a 23% revenue decline, 30% fall in gross profit, adjusted EBITDA turning negative, a $10M net loss, a large Pro Farm-related noncash impairment (~$179M), ongoing litigation with debt acceleration risk, and constrained liquidity. Management is pursuing remedies and operational stabilization, but significant legal and financial headwinds dominate the near-term outlook.Company Guidance
New CFO Appointment
Ezequiel Simmermacher joined as CFO with ~20 years of agricultural industry experience (Monsanto, CHS), strengthening financial leadership during a period of uncertainty.
Crop Nutrition Revenue Growth
Crop Nutrition revenues increased 15% year-over-year to $11.6 million, driven by micro-fertilizer demand and a favorable comparable base amid global supply/pricing uncertainties.
Strategic Shift to Asset-Light Seeds Model
Ongoing transition in Seeds and Integrated Products toward an asset-light, lower working-capital model is reducing near-term revenues but lowers exposure to lower-margin, working-capital intensive activity and improves long-term capital efficiency.
Operational Expense Reductions and Cost Control
Meaningful reduction in operating expenses and organizational streamlining initiatives during the quarter helped offset part of the decline in gross profit and support adjusted EBITDA resilience.
Improved Joint Venture Contributions
Joint venture results improved year-over-year and provided an incremental positive contribution to EBITDA in the quarter.
Balance Sheet Stability Sequentially
Total financial debt remained broadly stable sequentially at ~ $229 million, and net financial debt was approximately $214 million; cash, cash equivalents and short-term investments totaled about $14 million.
Underlying Gross Margin Trend (Excluding Nonrecurring Item)
Reported gross margin declined from 35% to 32%, but management noted that excluding a nonrecurring inoculants obsolescence adjustment, underlying gross margin performance was broadly in line with the prior year period.
Active Liability Management Efforts
Company is advancing reprofiling of Rizobacter debt (voluntary maturity extensions, discussions with bondholders) and continuing dialogue with stakeholders to preserve liquidity and enterprise value.
BIOX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BIOX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 11, 2026 | $0.54 | $0.45 | -16.94% |
Feb 05, 2026 | $0.60 | $0.53 | -11.17% |
Nov 12, 2025 | $1.87 | $1.71 | -8.56% |
Sep 09, 2025 | $2.67 | $2.24 | -16.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bioceres Crop Solutions (BIOX) report earnings?
Bioceres Crop Solutions (BIOX) is schdueled to report earning on Sep 03, 2026, Before Open (Confirmed).
What is Bioceres Crop Solutions (BIOX) earnings time?
Bioceres Crop Solutions (BIOX) earnings time is at Sep 03, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BIOX EPS forecast?
Currently, no data Available